TRK-700
Showing 1 - 25 of 287
CNS Tumor, Infantile Fibrosarcoma, Recurrent Acute Leukemia Trial in Canada, United States (Larotrectinib Sulfate)
Active, not recruiting
- Central Nervous System Neoplasm
- +4 more
- Larotrectinib Sulfate
-
Birmingham, Alabama
- +81 more
Jan 24, 2023
NTRK Gene Fusion - Positive Advanced or Recurrent Solid
Recruiting
- Advanced or Recurrent Solid Tumor Harboring an NTRK Gene Fusion
- Larotrectinib (Vitrakvi, BAY2757556)
-
Multiple Locations, JapanMany locations
Jan 20, 2023
Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Chuo Ku (TRK-950, Ramucirumab,
Not yet recruiting
- Gastric Adenocarcinoma
- +2 more
- TRK-950
- +2 more
-
Chuo Ku, JapanOsaka International Cancer Institute
Sep 14, 2023
Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis Trial in United States (ANK-700, Placebo)
Recruiting
- Multiple Sclerosis (MS)
- Relapsing Remitting Multiple Sclerosis
- ANK-700
- Placebo
-
Cullman, Alabama
- +14 more
Dec 13, 2022
Called VICTORIA to Learn More About How Well Larotrectinib Works
Active, not recruiting
- Solid Tumors Harboring NTRK Fusion
- Larotrectinib(Vitrakvi, BAY2757556)
- Data on other treatments
-
Whippany, New JerseyBayer
Aug 22, 2022
Topcon Tonometers CT-800 and TRK-2P and Haag-Streit Goldmann
Completed
- Intraocular Pressure
- Topcon CT-800
- Topcon TRK-2P
-
Andover, MassachusettsAndover Eye Associates
Jun 6, 2022
Solid Tumor Trial in Chuo Ku (TRK-950)
Recruiting
- Solid Tumor
- TRK-950
-
Chuo Ku, Tokyo, JapanNational Cancer Center Hospital
Jul 6, 2022
Chemo-induced Peripheral Neuropathy Trial (TRK-750/Placebo, Placebo/TRK-750)
Withdrawn
- Chemotherapy-induced Peripheral Neuropathy
- TRK-750/Placebo
- Placebo/TRK-750
- (no location specified)
Feb 27, 2022
Topcon Pachymeter TRK-3 to Evaluate Agreement and Precision
Completed
- Corneal Thickness
- SP-1P
-
Tokyo, JapanSamoncho Clinic
Jul 19, 2022
Solid Tumor, Colorectal Cancer, Cholangiocarcinoma Trial in France, United States (TRK-950, Irinotecan, Leucovorin)
Recruiting
- Solid Tumor
- +11 more
- TRK-950
- +14 more
-
Scottsdale, Arizona
- +13 more
Oct 2, 2022
Clinical Study of the Topcon Tonometer TRK-3
Completed
- Intraocular Pressure
- tonometer
-
Tokyo, Japan
- +1 more
Jul 19, 2022
Locally Advanced or Metastatic Solid Carcinomas, Colon Cancer, Cholangiocarcinoma Trial in Phoenix, Scottsdale, Lyon (TRK-950)
Completed
- Locally Advanced or Metastatic Solid Carcinomas
- +2 more
- TRK-950
-
Phoenix, Arizona
- +2 more
Oct 14, 2021
Prostate Cancer Trial in United States (TAK-700, Bicalutamide)
Active, not recruiting
- Prostate Cancer
-
Birmingham, Alabama
- +559 more
Dec 5, 2022
Variability Across Automated Biometry Devices
Recruiting
- Myopia
- Orbscan II
- +8 more
-
Houston, TexasBerkeley Eye Center
Sep 14, 2023
High Grade Glioma, Diffuse Intrinsic Pontine Glioma Trial in Worldwide (Larotrectinib, Larotrectinib surgical)
Recruiting
- High Grade Glioma
- Diffuse Intrinsic Pontine Glioma
- Larotrectinib
- Larotrectinib surgical
-
Aurora, Colorado
- +17 more
Aug 10, 2022
Width and HbA1C in Type 2 Diabetes Mellitus After Glycemic
Not yet recruiting
- Type 2 Diabetes
- Glycated hemoglobin (HbA1C)
- +2 more
- (no location specified)
Sep 28, 2023
Using Phase-resolved Functional Lung MRI in COVID-19
Recruiting
- Pulmonary Function
- Functional lung MRI
-
Beijing, Beijing, ChinaBeijing Chaoyang Hospital
Jul 5, 2023
Two Swept Source Optical Coherence Tomography Biometers
Completed
- Cataract
- Argos
- IOLMaster 700
-
Frankfort, IllinoisMultack Eye Care
Feb 17, 2023
Acquired Brain Injury, Subarachnoid Hemorrhage, Traumatic Brain Injury Trial in Zwolle, Wijk Aan Zee
Enrolling by invitation
- Acquired Brain Injury
- +3 more
-
Zwolle, Overijssel, Netherlands
- +1 more
Aug 11, 2022
Stress, Sleep, Craving Trial in Colorado Springs (Ashwagandha, Placebo)
Completed
- Stress
- +3 more
- Ashwagandha
- Placebo
-
Colorado Springs, ColoradoUniversity of Colorado Colorado Springs
Jun 18, 2022
Targeted Drugs for Pulmonary Hypertension UsingComputerized
Recruiting
- Pulmonary Hypertension
-
Beijing, Beijing, ChinaFuwai Hospital, Chinese Academy of Medical Sciences
May 8, 2022
Cancer (With or Without Metastasis) Trial in Houston (TSN084)
Recruiting
- Cancer (With or Without Metastasis)
-
Houston, TexasMD Anderson Cancer Center
Apr 22, 2022
Locally Advanced Solid Tumors, Metastatic Solid Tumors, Lymphoma Trial in Worldwide (Oral repotrectinib (TPX-0005))
Recruiting
- Locally Advanced Solid Tumors
- +3 more
- Oral repotrectinib (TPX-0005)
-
Los Angeles, California
- +27 more
Aug 9, 2022
Called EPI VITRAKVI to Compare Treatment Results in Infantile
Completed
- Locally Advanced or Metastatic Infantile Fibrosarcoma Harboring an NTRK Gene Fusion
- Infantile Fibrosarcoma
- Larotrectinib (Vitrakvi, BAY2757556)
- Standard of Care
-
Multiple Locations, FranceMultiple Locations
Jan 10, 2023